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ABSTRACT: A small library of Ir-MaxPHOX catalysts has been applied to the 
asymmetric hydrogenation of N-aryl imines. A structure-activity analysis of the three 
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chiral center MaxPHOX ligand has been performed. Using complex 1b, the 
hydrogenation of N-aryl imines took place with up to 96% enantiomeric excess at 
atmospheric pressure of hydrogen and low temperature. The impact of the stereochemical 
information at the phosphorous center is small with respect the selectivity, but large with 
respect the catalyst activity. Non P-stereogenic analogs of MaxPHOX were also 
synthesized and tested but provided lower selectivity. The selectivity observed could be 
explained by taking into account that the actual catalysts were cyclometalated imine 
complexes formed in situ. [IrHCl(MaxPHOX)(imine)] complexes 9 and 10 were 
synthesized and characterized by X-ray crystallography. These complexes, via chloride 
abstraction, provided the active catalytic species with the same levels of selectivity. 
Finally, the influence of the counter ion on the catalyst performance was also studied.  
  
INTRODUCTION 
Many active pharmaceutical ingredients and agrochemicals contain chiral amines. In 
this regard, there is considerable interest in developing efficient methods that provide 
single enantiomers of such compounds, thus avoiding inefficient racemate resolutions. 
Metal-catalyzed asymmetric hydrogenation of imines is one of the methods of choice in 
terms of industrial applicability.1 While ruthenium has provided excellent results in 
transfer-hydrogenation reactions, iridium has shown better performance for the direct 
hydrogenation of imines.2 In this field, Pfaltz and others have shown that Ir-P,N catalysts 





Figure 1: General structure of the MaxPHOX ligands.  
We recently developed the MaxPHOX ligand system, which is built from three 
fragments—an amino alcohol, an amino acid and a P-stereogenic phosphinous acid 
(Figure 1).4 The Ir-MaxPHOX complexes have shown outstanding selectivity in the 
hydrogenation of cyclic enamides.5 One of the key advantages of the MaxPHOX ligand 
is the structural diversity arising from its possible configurations and substitution patterns, 
which can be adapted to a specific reaction. To demonstrate this versatility, here we report 
on the asymmetric hydrogenation of N-aryl imines using the Ir-MaxPHOX catalyst 
system. To study the influence of the stereogenic center of the phosphorus atom, non-P-
stereogenic MaxPHOX ligands were also synthesized and evaluated in the asymmetric 
hydrogenation. We spotted a catalyst that hydrogenates N-aryl imines with up to 96% 
enantiomeric excess (ee) at atmospheric pressure of hydrogen (balloon). The putative 
imine-cyclometalated catalyst derivatives were also isolated, characterized by X-ray 





Figure 2: Ir-MaxPHOX catalysts used in the present study.  
 
RESULTS AND DISCUSSION 
Ligand Synthesis. The iridium catalysts used in the present study are shown in Figure 
2. Twelve P-stereogenic MaxPHOX catalysts were employed. These arise from the four 
possible diastereomeric configurations 1, 2, 3 and 4, plus three distinct oxazoline 
substitutions, R = Ph, (a), R = iPr (b), and R = tBu (c). The synthesis of these ligands (1a-
c, 2a-c, 3a-c and 4a-c) involved the coupling of amino acid, amino alcohol and P-
stereogenic phosphinous acid fragments and final complexation with an iridium 
precursor.5 The corresponding non-P-stereogenic 5a and 5b ligands with a 
dicyclohexylphosphine moiety were also synthesized in a similar fashion, as shown in 
Scheme 1. N-Boc protected valine was coupled to either D- or L-valinol. The unprotected 
amino alcohols 6a-b were then coupled to a phosphinyl mesyl mixed anhydride derived 
from dicyclohexylphosphinous acid borane.6 This reaction is highly selective for amine 
nucleophiles and it provided borane-protected aminophosphines 7a-b. Reaction with 
SOCl2 and treatment with NaHCO3 gave the protected phosphine-oxazoline ligands 8a-
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b. Finally, borane deprotection with pyrrolidine, treatment with [Ir(cod)Cl]2, and counter 
ion exchange with NaBArF afforded non P-stereogenic catalysts 5a and 5b (Scheme 1).  
 





































































Asymmetric hydrogenation of imines. With the Ir-MaxPHOX catalysts in hand, we 
proceeded to study their performance in the hydrogenation of acetophenone N-phenyl 
imine with 1 mol% catalyst loading in DCM at 55 bar of H2 (Table 1). The best results 
were obtained for catalysts with configurations 1 and 4, the isopropyl group on the 
oxazoline providing the best results. Thus, complex 1b gave the highest enantiomeric 
excess (89% ee) and 4b the second best (85% ee) but with the opposite configuration. 
Catalysts 1b and 4b would be enantiomers of each other, except that the chirality at 
phosphorus is inverted. This result suggests that the stereochemical configuration at 
phosphorus had a limited impact on the selectivity. On the other hand, we observed that 
the configuration of the chiral center on the backbone of the ligand had a major effect on 
the selectivity. Catalysts 2b and 3b, while having the same configuration at the P-center 
and oxazoline with respect 1a and 4b, provided much lower selectivity. We called this 
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phenomenon the “tail effect”. We believe this behavior is associated with conformational 
changes within the Ir-P,N six-membered ring chelate. Finally, non P-stereogenic catalysts 
5a and 5b were also tested, providing 57% and 81% ee, respectively. These results 
demonstrate that although the chiral oxazoline plays the most important role for our 
system, the presence of additional stereogenic centers both at the phosphine and the tail 
position is beneficial in terms of selectivity.  
 
Table 1: Hydrogenation of acetophenone N-phenyl imine. Influence of the oxazoline 











a) All reactions were left to run overnight and went to 100% conversion as shown by 
1H NMR spectroscopy. b) Enantiomeric excess was determined by chiral HPLC.  
 
With the best catalyst in hand (1b), we then studied the influence of hydrogen pressure, 
solvent and temperature on the reaction outcome (Table 2). Selectivity was relatively 
insensitive to the reaction pressure. In this regard, a reduction in the pressure from 55 bar 
to 3 bar produced only a slight increase in enantiomeric excess (from 89 to 90% ee, Table 
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2, entries 1 and 2). The pressure was even reduced to the atmospheric pressure of H2 
(balloon), giving the same results with respect to conversion and selectivity (Table 2, 
entry 3). Switching the reaction solvent from DCM to more coordinating solvents like 
EtOAc or MeOH caused a dramatic drop in selectivity (Table 2, entries 4 and 5). A 
reduction in reaction temperature enhanced selectivity. Thus at 0 ºC and atmospheric H2 
pressure, the imine was reduced with 94% ee and lowering the temperature to –20 ºC 
afforded the reduced amine with 96% ee (Table 2, entries 7 and 8). At this point, catalyst 
4b that only differs from the configuration at the P-center and which provided the second 
best selectivity (85% ee) in the initial catalysts screening at 55 bar, was also tested at 
atmospheric H2 pressure (Table 2, entry 9). We observed that 4b was considerably less 
active; since, after 72h, only 8% conversion was achieved. This demonstrates that while 
the chirality on phosphorous has a small influence on the selectivity it has a great impact 
on the catalyst activity.  
 




Entry Cat H2 (bar) Solvent Temp (ºC) Conv (%)b ee (%)c 
1 1b 55 DCM rt 100 89 
2 1b 3 DCM rt 100 90 
3 1b balloon DCM rt 100 90 
4 1b 3 EtOAc rt 100 66 
5 1b 3 MeOH rt 100 45 
6 1b 3 Toluene rt 100 85 
7 1b balloon DCM 0 100 94 
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8 1b balloon DCM –20 100 96 
9d 4b balloon DCM rt 8 nd 
a) All reactions were left to run overnight unless otherwise noted. b) Conversion was 
determined by 1H NMR spectroscopy. c) Enantiomeric excess was determined by chiral 
HPLC. d) Reaction time 72h.  
 
Once the reaction parameters had been optimized, we proceeded to assess the scope of 
the hydrogenation with catalyst 1b with various aryl imines. Reduction of p- and m-
methoxyacetophenone N-phenyl imine proceeded with 95% and 92% ee, respectively 
(Table 3, entries 2 and 3). However, o-methoxyacetophenone N-phenyl imine was 
hydrogenated with only 28% ee (Table 3, entry 4). This decrease in selectivity is most 
likely due to a less favorable E/Z ratio of the starting imine.7 N-Phenyl imines derived 
from p-chloroacetophenone and methyl 2-naphthyl ketone were both reduced, with 94% 
ee (Table 3, entries 5 and 6). Imine derived from ethyl phenyl ketone was also reduced, 
showing a lower enantiomeric excess (74%, Table 3, entry 7).7 Finally, acetophenone 
imines derived from other anilines, such as p-anisidine, p-toluidine and 2,3-
dimethylaniline, were again reduced with excellent selectivity and with 90-95% ee. 
 
Table 3: Hydrogenation of aryl amines with catalyst 1b.a 

































a) Unless specified all reactions were conducted overnight with 1 mol% catalyst loading 
in DCM at –20°C with atmospheric H2 pressure (balloon). b) Reaction carried out with 2 
mol% of catalyst loading at 3 bar of H2. c) Reaction conducted at room temperature. 
 
Effect of the counter ion on the reaction rate, catalyst intermediates and 
mechanistic considerations. Since catalyst 1b showed activity and selectivity that 
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paralleled the best P,N-Ir systems reported for the hydrogenation of N-phenyl ketimines, 
we studied the rate of the reaction and how the counter ion influences the performance of 
the catalyst.8 The hydrogenation of acetophenone N-phenyl imine using 1 mol% of 1b-
BArF and 1b-BF4 at atmospheric pressure of hydrogen was monitored by GC analysis, 
as shown in Figure 4. Catalyst 1b-BArF proved extremely active, and 100% conversion 
was observed after 50 min using only atmospheric H2 pressure. The use of a smaller 
counter ion, such as BF4, resulted in a slower reaction and full conversion was only 
achieved after 150 min (2.5 h). Furthermore, the use of BF4 as counter ion had a 
significant deleterious effect on selectivity since the product amine was obtained with 
only 41% ee (90% ee using BArF, Figure 3).  
 
Figure 3: Conversion vs. reaction time graph for the hydrogenation of acetophenone N-
phenyl imine using catalysts 1b with BArF and BF4 counter ions. Reactions were run at 























Pfaltz and coworkers have recently shown that an imine iridacycle is the actual catalyst 
when using Ir-P,N complexes.9 These cyclometallated Ir (III) species form spontaneously 
upon reaction between the iridium complex and the starting imine under hydrogen 
pressure. With this in mind, and to further increase knowledge of the true catalytic system, 
we questioned whether these intermediates are also involved in our Ir-MaxPHOX system. 
Complexes 1b and 3b were reacted under hydrogen atmosphere with acetophenone N-
phenyl imine in THF (Scheme 2). Treatment of the reaction mixture with LiCl afforded 
the corresponding cyclometallated iridium hydride neutral complexes 9 and 10.9 These 
complexes were isolated as a pale yellow solids by filtration on silica gel. 1H and 31P 
NMR analysis confirmed compounds 9 and 10 as diastereomerically pure compounds. A 
single resonance for the Ir-H was observed at –19.76 ppm (d, JP = 26 Hz) and –19.62 ppm 
(d, JP = 23 Hz) for 9 and 10, respectively. It should be noted that heteroleptic octahedral 
complexes such as 9 and 10 can, in principle, provide various diastereomers. It is therefore 
remarkable that in this case a single stereoisomer was generated.  
 




To further characterize these species, compounds 9 and 10 were crystalized from 
hexane/DCM mixtures to obtain single crystals for X-ray analysis. The resulting solid 
state structures are shown in Figure 4. As expected, the iridium (III) displays octahedral 
coordination. The phosphino-oxazoline ligand and the cyclometallated imine ligand are 
perpendicular to each other, with the oxazoline nitrogen atom trans with respect the 
phenyl ring. The chiral center of the oxazoline fragment seems to control the coordination 
of the imine nitrogen. In both complexes, the C=N-Ph group is positioned away from the 
isopropyl substituent of the oxazoline ring. Finally, the hydride and chloride ligands are 




Figure 4: X-ray structures of iridacycles 9 and 10. Ortep diagram shows ellipsoids at 50% 






To verify whether the isolated imine iridacycles can be used as precatalysts, compound 
9 was tested in the hydrogenation of imines. Thus, 1 mol% of 9 was treated with 2 
equivalents of NaBArF in order to produce the active catalyst by counter ion exchange 
(Scheme 3). The use of this mixture as catalyst afforded the reduced product with 60% 
conversion and 91% ee. Despite the lower conversion observed, that can be justified by 
an inefficient chloride abstraction reaction, this result strongly suggests that the cationic 
cyclometallated complex arising from chloride abstraction of 9 is an active species in the 
catalytic cycle.  
 




For several years, the mechanism of imine reduction by iridium catalysts has been the 
subject of debate.10 During the preparation of this manuscript, Wiest and coworkers 
published a theoretical DFT mechanistic study of this process.11 The authors took into 
account the findings of Pfaltz and considered cyclometalated iridium(III)-hydride species 
as the intermediates in the catalytic cycle. The study concluded that the hydrogenation 
with the cyclometalated precursors proceeds through an outer sphere mechanism, as 
depicted in a simplified manner in Scheme 4. According to this proposal, the active 
species in the catalytic cycle would be the cationic hydride-dihydrogen complex I, which, 
upon proton transfer, activates the amine to form the neutral dihydride complex II. The 
stereodetermining step is the hydride transfer trans to phosphorus to the activated imine 
to yield complex III.  
 
Scheme 4: Outer sphere mechanism for the iridium-catalyzed hydrogenation of imines.  
 
 
Our results are in agreement with this proposal. In this system, the imine ligand and the 
oxazoline isopropyl substituent are the fragments that surround the hydride transferred to 
the protonated imine in the stereodetermining step (Figure 5). Analyzing the selectivity 
observed with the four stereoisomers of MaxPHOX ligands (1b, 2b, 3b and 4b, Table 1), 
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we can conclude that the chirality on phosphorus and the tail position is highly relevant. 
The intriguing question now is that since phosphine and the tail moiety are placed far 
away from the reacting center, why does the chirality on these fragments have such an 
impact on selectivity?  
Two concurrent effects could explain this behavior. First, small conformational 
differences on the reacting site may provide a selectivity bias. Observing the pseudo-
enantiomeric reacting sites (Figure 5) in complex 9, the N-phenyl of the cyclometalated 
imine is tilted upwards, while for 10, the N-phenyl ring is almost perpendicular to the Ir-
imine metallacycle. These conformational differences of the N-phenyl group are 
ultimately governed by the configuration of the phosphine and tail positions and should 
lead to a difference in selectivity between 9 and 10.12 
 
Figure 5: Reacting sites for complexes 9 and 10 as extracted from the corresponding X-
ray structures. The phosphine and ligand backbone have been deleted for clarity. View 
along the Cl-Ir bond axis (green dot). The green dot also corresponds to the hydride 





A second effect would be the relative stability of complexes IVa/IVb with a vacant 
coordination site (Scheme 5). It is easy to envisage that the coordination of H2 to either 
complex IVa or IVb would provide a different selectivity outcome. Therefore, the 
stereochemical stability of the transient iridium complexes appears to be essential to 
guarantee high selectivity during hydrogenation. This notion is in agreement with the fact 
that in our case 9 and 10 have the stereochemistry of IVa, while Pfaltz and co-workers, 
reported the X-ray crystal structure of an [IrH(THF)(PHOX)(imine)]+ complex, where 
the cyclometalated phenyl group is trans to phosphine and which, upon removal of the 
solvent molecule, provides a complex with the same stereochemistry at the metal as IVb.9 
We believe that the chirality on phosphorous and the tail positions in the MaxPHOX 
ligand system are important for stabilizing the arrangement of the ligands around the 
metal center in the true catalytic species.  
 




From a small family of P-stereogenic Ir-MaxPHOX precatalysts, we pinpointed 
complex 1b, which shows activity and selectivity that matches the best Ir-P,N systems in 
the hydrogenation of acyclic imines. Catalyst 1b hydrogenated N-aryl imines with up to 
96% ee at atmospheric pressure of hydrogen and low temperature. Catalyst 4b that only 
differs from the configuration at the P-center was significantly less active, demonstrating 
that the chirality on phosphorous has a great impact on the catalyst activity. Non-P-
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stereogenic analogs of Ir-MaxPHOX were also synthesized and provided lower 
selectivity. The nature of the counter ion greatly influences the reaction outcome; smaller 
counter ions (e.g. BF4) provided slower reactions and reduced enantiomeric excess. The 
active catalyst species are cationic iridium complexes that have an imine molecule from 
the substrate incorporated via cyclometalation. Cyclometalated 
[IrHCl(MaxPHOX)(imine)] complexes 9 and 10 were isolated and characterized by X-
ray crystallography. Chloride abstraction with NaBArF on 9 provided a functional 
catalytic system with the same level of selectivity as that obtained with catalyst 1b. While 
the chirality of phosphorus and the tail position are away from the reacting center, they 
are non-innocent with respect the performance of the catalyst. We propose that these 
moieties modify the reacting site by inducing small conformational differences on the N-
phenyl ring of the cyclometalated imine and by stabilizing the relative arrangement of the 
imine and phosphine-oxazoline ligands around the iridium center.  
EXPERIMENTAL SECTION 
General methods. All reactions were carried out in dried solvents under nitrogen 
atmosphere. Et2O and CH2Cl2 were dried in a purification system. Other commercially 
available reagents and solvents were used with no further purification. Thin layer 
chromatography was carried out using TLC-aluminum sheets with silica gel. Flash 
chromatography was performed by using an automated chromatographic system with 
hexane/ethyl acetate or hexane/dichloromethane gradients as eluent unless otherwise 
stated. NMR spectra were recorded at 23°C on a 400 MHz, 500 MHz or 600 MHz 
apparatus. 1H NMR and 13C NMR spectra were referenced either to relative internal TMS 
or to residual solvent peaks. 31P NMR spectra were referenced to phosphoric acid. Optical 
rotations were measured at room temperature (25°C) and concentration is expressed in 
g/100 mL. Melting points were determined using a Büchi apparatus and were not 
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corrected. IR spectra were recorded in a FT-IR apparatus. HRMS were recorded in a 
LTQ-FT spectrometer using the Nanoelectrospray technique. Catalysts 1, 2, 3 and 4 were 
prepared as described previously.5 
Dicyclohexyl phosphinous acid borane.6 In a N2 purged round bottom flask 2g of 
chlorodicyclohexylphosphine (8.59 mmol, 1 eq) were weighed. Anhydrous THF (8 mL) 
was added and the reaction was cooled to 0 ºC. Then, 815 µL (8.59 mmol, 1 eq) of 
BH3.SMe2 were added dropwise. The reaction was left stirring 1 hour at room 
temperature. Then it was cooled again to 0 ºC and 2g (51.5 mmol, 6 eq) of NaOH solved 
in 32 mL of H2O/THF (1/2) were slowly added. The solution was left stirring overnight 
at room temperature. Using a diluted solution of aqueous HCl, the reaction was quenched 
and brought to neutral pH. It was then extracted thrice with Et2O. The organic layers were 
dried over MgSO4 and concentrated on a rotary evaporator under reduced pressure. 
Purification by column chromatography (SiO2, hexanes:EtOAc) yielded 1.67 g (85%) of 
the desired product as a white solid. 1H NMR (400 MHz, CDCl3) δ; 2.68 (br s, 1H), 1.92 
– 1.68 (m, 12H), 1.56 – 1.40 (m, 2H), 1.40 – 1.20 (m, 8H), 0.97 – 0.01 (m, 3H, P–BH3) 
ppm.  
General procedure for the synthesis of aminophosphines (7a-b). A solution of 
dicyclohexylphosphinous acid borane (1 eq) and methansulfonic anhydride (1.2 eq) in 
CH2Cl2 (0.2M) was cooled to 0 ºC. To this solution, anhydrous NEt3 (2.5 eq) was slowly 
added, and the mixture was stirred 1 h at 0 ºC. The corresponding amine (1.5 eq) was then 
added and the solution was stirred overnight at room temperature. Water was added and 
the mixture was allowed to warm to room temperature. The organic layer was separated 
and the aqueous phase was extracted twice with CH2Cl2. The combined extracts were 
washed with brine and concentrated under reduced pressure. Purification by flash 
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chromatography (SiO2, hexanes:EtOAc) yielded the corresponding products as white 
solids.  
(S)-2-((dicyclohexylphosphanyl)amino)-N-((S)-1-hydroxy-3-methylbutan-2-yl)-3-
methylbutanamide borane (7a). White solid. Yield: 41% (150 mg). Mp: 200–201 ºC. 
[α]D: –5.6 (c 0.53, CHCl3). IR (KBr) ʋmax: 3297, 2918, 2386, 2343 and 1648 cm-1. 1H 
NMR (400 MHz, CDCl3) δ; 5.9 (br d, J = 7 Hz, 1H), 3.75 – 3.60 (m, 3H), 3.52 (td, J = 
10, 6 Hz, 1H), 2.77 (br s, 1H), 2.23 (dd, J = 10, 4 Hz, 1H), 1.95 – 1.60 (m, 14H), 1.43 – 
1.15 (m, 10H), 0.99 (d, J = 4 Hz, 3H), 0.98 – 0.96 (m, 6H), 0.96 (d, J = 4 Hz, 3H), 0.78 
– -0.07 (m, P–BH3).ppm. 13C NMR (101 MHz, CDCl3) δ; 174.3 (C), 63.9 (CH), 62.3 
(CH), 57.7 (CH), 35.2 (d, JP = 32 Hz, CH), 34.9 (d, JP = 41 Hz, CH), 33.7 (d, JP = 5 Hz, 
CH), 28.8 (CH), 26.8 – 25.2 (m, 10 x CH2), 19.4 (CH3), 19.0 (CH3), 18.9 (CH3), 18.7 
(CH3) ppm. 31P NMR (202 MHz, CDCl3) δ; 73.3 – 71.1 (m, P–BH3) ppm. HRMS 
(nanoESI-Orbi) m/z: [M + H]+ Calcd for C22H46O2N2BP 413.3463; Found 413.3458. 
(S)-2-((dicyclohexylphosphanyl)amino)-N-((R)-1-hydroxy-3-methylbutan-2-yl)-3-
methylbutanamide borane (7b). White solid. Yield: 59% (214 mg). Mp: 122–123 ºC. 
[α]D: +25.0 (c 0.58, CHCl3). IR (KBr) ʋmax: 3318, 2935, 2854, 2368 and 1652 cm-1. 1H 
NMR (400 MHz, CDCl3) δ; 5.86 (br s, 1H), 3.72 – 3.65 (m, 3H), 3.41 (td, J = 10, 7 Hz, 
1H), 2.78 (br s, 1H), 2.16 (br d, J = 8 Hz, 1H), 1.97 – 1.60 (m, 14H), 1.44 – 1.14 (m, 
10H), 1.00 (d, J = 7 Hz, 3H), 0.99 – 0.93 (m, 9H), 0.72 – 0.08 (m, BH3) ppm. 13C NMR 
(101 MHz, CDCl3) δ; 174.5 (C), 63.7 (CH2), 62.9 (d, J = 2 Hz, CH), 57.6 (CH), 35.1 (d, 
JP = 43 Hz, CH), 34.9 (d, JP = 36 Hz, CH), 33.4 (d, J = 6 Hz, CH), 28.8 (CH), 26.8 – 25.2 
(m, 10 x CH2), 19.6 (CH), 19.4 (CH), 19.0 (CH), 18.9 (CH) ppm. 31P NMR (202 MHz, 
CDCl3) δ; 74.5 – 69.7 (m, P–BH3) ppm. HRMS (nanoESI-Orbi) m/z: [M + H]+ Calcd for 
C22H46O2N2BP 413.3463; Found 413.3461. 
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General procedure for the synthesis of phosphino-oxazolines (8a-b). The 
corresponding aminophosphane (1 eq) was dissolved in CH2Cl2 (0.08 M) and SOCl2 (2.4 
eq) was added drop wise at 0 ºC. The solution was stirred 4 h at room temperature. The 
solution was then cooled down to 0 ºC and NaHCO3 saturated aqueous solution was added 
slowly until pH 8-9. The mixture was left stirring for 15 min at room temperature. The 
two phases were separated and the aqueous phase was extracted twice with CH2Cl2. The 
combined organic layers were washed with brine. The organic layer was dried over 
MgSO4 and concentrated on a rotary evaporator under reduced pressure. Purification by 
column chromatography (SiO2, hexanes:EtOAc) yielded the desired products as white 
solids. 
1,1-dicyclohexyl-N-((S)-1-((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)-2-
methylpropyl)phosphanamine borane (8a). White Solid. Yield: 96% (120 mg). Mp: 
122–123 ºC. [α]D: –29.3 (c 0.53, CHCl3). IR (KBr) ʋmax: 3318, 2922, 2845, 2390, 2330 
and 1666 cm-1. 1H NMR (400 MHz, CDCl3) δ; 4.27 (t, 1H), 4.01 (t, J = 8 Hz, 1H), 3.94 
– 3.76 (m, 2H), 2.26 (br d, J = 10 Hz, 1H), 1.99 – 1.59 (m, 14H), 1.47 – 1.16 (m, 10H), 
1.01 (d, J = 7 Hz, 3H), 0.94 – 0.88 (m, 9H), 0.70 – 0.10 (m, 3H, BH3) ppm. 13C NMR 
(101 MHz, CDCl3) δ; 168.1 (C), 71.9 (CH), 70.9 (CH2), 56.1 (d, J = 2 Hz, CH), 35.8 (d, 
JP = 34 Hz, CH), 34.3 (d, JP = 44 Hz, CH), 34.0 (d, J = 4 Hz, CH), 33.0 (CH), 26.9 – 25.2 
(m, 10 x CH), 19.2 (CH3), 18.5 (CH3), 18.2 (CH3), 18.1 (CH3) ppm. 31P-NMR (202 MHz, 
CDCl3) δ 73.0 – 71.2 (m, P-BH3) ppm. HRMS (nanoESI-Orbi) m/z: [M + H]+ Calcd for 
C22H44ON2BP 395.3357; Found 395.3350. 
1,1-dicyclohexyl-N-((S)-1-((R)-4-isopropyl-4,5-dihydrooxazol-2-yl)-2-
methylpropyl)phosphanamine borane (8b). White Solid. Yield: 99% (66 mg). Mp: 
123.5–124.5 ºC. [α]D: +16.0 (c 0.31, CHCl3). IR (KBr) ʋmax: 3328, 2916, 2398, 2362 and 
1667 cm-1. 1H NMR (400 MHz, CDCl3) δ; 4.28 (dd, J = 9, 8 Hz, 1H), 3.97 – 3.73 (m, 
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3H), 2.14 (dd, J = 10, 3 Hz, 1H), 1.97 – 1.59 (m, 14H), 1.47 – 1.17 (m, 10H), 0.98 (d, J 
= 7 Hz, 3H), 0.96 – 0.91 (m, 6H), 0.89 (d, J = 7 Hz, 3H), 0.72 – 0.05 (m, 3H, BH3) ppm. 
13C NMR (101 MHz, CDCl3) δ; 168.2 (C), 71.9 (CH), 70.4 (CH2), 55.9 (CH), 35.7 (d, JP 
= 33 Hz, CH), 34.3 (d, JP = 44 Hz, CH), 33.8 (CH), 32.5 (CH), 27.0 – 25.1 (m, 10 x CH2), 
19.2 (CH3), 18.4 (CH3), 18.3 (CH3), 18.1(CH3).ppm. 31P NMR (202 MHz, CDCl3) δ; δ 
73.6 – 72.0 (m, P-BH3) ppm. HRMS (nanoESI-Orbi) m/z: [M + H]+ Calcd for 
C22H44ON2BP 395.3357; Found 395.3349.  
General procedure for the preparation of [Ir(P,N)(COD)]BArF complexes (5a-b). 
The corresponding borane protected ligand (1 eq) was dissolved in freshly distilled 
pyrrolidine (0.06 M) and stirred for 16 h at 90 ºC. Afterwards, pyrrolidine was removed 
in vacuo. When no pyrrolidine remained, the crude was further dried under vacuum for 
30 min at 50 ºC (the crude was under N2 during all the procedure). A solution of 
[Ir(COD)(Cl)]2 (0.5 eq) in CH2Cl2 (0.06 M) was added to the free ligand via cannula. The 
resulting mixture was stirred for 40 min at room temperature. NaBArF (1 eq) was then 
added and the solution was stirred 1 h more at room temperature. The resulting crude was 
filtered through a small plug of silica gel, (first washed with Et2O) under N2, eluting with 
hexanes:CH2Cl2 (50-100%). The orange fraction was collected and concentrated to yield 
the corresponding iridium complexes as deep orange solids. 
[Ir(8a)(COD)]BArF (5a). Orange solid. Yield: 74% (145 mg). Mp: 167–168 ºC. [α]D: 
+46.9 (c 0.60, CHCl3). IR (KBr) ʋmax: 2929, 2855, 1628, 1276 and 1129 cm-1. 1H NMR 
(400 MHz, CDCl3) δ; 1H NMR (400 MHz, Chloroform-d) δ 7.75 – 7.68 (m, 8H), 7.53 (br 
s, 4H), 4.84 – 4.75 (m, 1H), 4.55 – 4.47 (m, 2H), 4.26 (t, J = 10 Hz, 1H), 4.12 – 4.04 (m, 
1H), 3.95 – 3.86 (m, 1H), 3.54 – 3.47 (m, 1H), 3.47 – 3.36 (m, 2H), 2.42 – 2.34 (m, 2H), 
2.26 – 2.18 (m, 2H), 2.16 – 1.52 (m, 17H), 1.42 – 1.15 (m, 12H), 1.09 (d, J = 7 Hz, 3H), 
1.02 (d, J = 7 Hz, 3H), 0.88 (d, J = 7 Hz, 3H), 0.82 (d, J = 7 Hz, 3H) ppm. 13C NMR (101 
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MHz, CDCl3) δ; 175.0 (C), 161.7 (q, JB = 50 Hz, 4 x C), 134.8 (8 x CH), 129.5 – 128.3 
(m, 8 x C), 124.5 (q, JF = 273 Hz, 8 x CF3), 117.40 (hept, JF = 4 Hz, 4 x CH), 92.70 (d, 
JP = 11 Hz, CH), 89.0 (d, JP = 13 Hz, CH), 69.9 (CH), 69.2 (CH), 62.6 (CH), 59.9 (CH), 
59.7 (CH), 41.1 (d, JP = 32 Hz, CH), 38.2 (CH), 37.1 (d, JP = 33 Hz, CH), 36.0 (CH2), 
31.9 (CH), 31.9 (CH2), 29.6 – 25.6 (m, 12 x CH2), 20.6 (CH3), 19.9 (CH3), 18.6 (CH3), 
15.1 (CH3) ppm. 31P NMR (202 MHz, CDCl3) δ; 60.7 (s) ppm. HRMS (nanoESI-Orbi) 
m/z: [M]+ Calcd for C30H53ON2IrP 681.3519; Found 681.3502. HRMS (nanoESI-Orbi) 
m/z: [M]‒ Calcd for C32H12BF24 863.0654; Found 863.0634. 
[Ir(8b)(COD)]BArF (5b). Orange solid. Yield: 52% (102 mg). [α]D: –41.2 (c 0.49, 
CHCl3). IR (KBr) ʋmax: 2940, 2856, 1622, 1351 and 1271 cm-1. 1H NMR (400 MHz, 
CDCl3) δ; 7.74 – 7.67 (m, 8H), 7.53 (br s, 4H), 4.80 – 4.73 (m, 1H), 4.61 (p, J = 7 Hz, 
1H), 4.54 (dd, J = 10, 4 Hz, 1H), 4.28 (t, J = 10 Hz, 1H), 4.05 – 3.99 (m, 1H), 3.90 (dt, J 
= 10, 3 Hz, 1H), 3.82 – 3.76 (m, 1H), 3.39 – 3.31 (m, 1H), 2.52 – 1.16 (m, 33H), 1.11 (d, 
J = 7 Hz, 3H), 0.93 (d, J = 7 Hz, 3H), 0.92 (d, J = 7 Hz, 3H), 0.74 (d, J = 7 Hz, 3H) ppm. 
13C NMR (101 MHz, CDCl3) δ; 175.0 (C), 161.7 (q, JB = 50 Hz, 4 x C), 134.8 (8 x CH), 
129.5 – 128.3 (m, 8 x C), 124.5 (q, JF = 273 Hz, 8 x CF3), 117.40 (hept, JF = 4 Hz, 4 x 
CH), 93.8 (d, JP = 12 Hz, CH), 92.0 (CH), 70.3 (CH2), 68.4 (CH), 61.7 (CH), 60.1 (CH), 
58.7 (CH), 39.7 (d, JP = 37 Hz, CH), 37.6 (d, JP = 29 Hz, CH), 35.3 (CH2), 31.8 (CH), 
30.9 – 25.5 (m, 13 x CH2 and 1 x CH), 20.1 (CH3), 18.9 (CH3), 16.2 (CH3), 14.2 (CH3) 
ppm. 31P NMR (202 MHz, CDCl3) δ; 59.7 (s) ppm. HRMS (nanoESI-Orbi) m/z: [M]+ 
Calcd for C30H53ON2IrP 681.3519; Found 681.3501. HRMS (nanoESI-Orbi) m/z: [M]‒ 
Calcd for C32H12BF24 863.0654; Found 863.0654. 
[Ir(P*,N)(COD)]BF4 (1b-BF4). 45 mg of (R)-1-tert-butyl-N-((R)-1-((S)-4-(iso-
propyl)-4,5-dihydrooxazol-2-yl)-2-methylpropyl)-1-methylphosphanamine borane 
(0.148 mmol, 1 eq) was dissolved in freshly distilled pyrrolidine (0.06 M) and stirred for 
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16 h at 90 ºC. Afterwards pyrrolidine was removed in vacuo. When no pyrrolidine 
remained, the crude was further dried under vacuum for 30 min at 50 ºC (the crude was 
under N2 during all the procedure). 50 mg of [Ir(COD)(Cl)]2 (0.074 mmol, 0.5 eq) in 
CH2Cl2 (2 mL) were added to the free ligand. The resulting mixture was stirred for 40 
min at room temperature. Then, 17 mg of NaBF4 (0.148 mmol, 1 eq) were added and the 
solution was left stirring overnight at room temperature. Purification by flash 
chromatography (SiO2, DCM:MeOH) yielded 63 mg (63%) of product as an orange/red 
solid. Mp: 200–202 ºC. [α]D: –18.5 (c 0.40, CHCl3). IR (KBr) ʋmax: 3346, 2956, 2874, 
1620 and 1213 cm-1. 1H NMR (400 MHz, CDCl3) δ; 5.11 – 5.02 (m, 1H), 4.91 – 4.84 (m, 
1H), 4.69 (t, J = 10 Hz, 1H), 4.56 (dd, J = 10, 4 Hz, 1H), 4.19 – 4.13 (m, 1H), 4.02 (dt, J 
= 10, 4 Hz, 1H), 3.63 – 3.57 (m, 1H), 3.57 – 3.46 (m, 1H), 2.63 – 2.53 (m, 1H), 2.53 – 
2.42 (m, 1H), 2.39 – 2.17 (m, 3H), 2.16 – 2.06 (m, 2H), 1.84 – 1.65 (m, 4H), 1.42 (d, JP 
= 8 Hz, 3H), 1.22 (d, JP = 15 Hz, 9H), 1.10 (d, J = 7 Hz, 3H), 1.01 (d, J = 7 Hz, 3H), 0.98 
(d, J = 7 Hz, 3H), 0.79 (d, J = 7 Hz, 3H) ppm. 13C NMR (101 MHz, CDCl3) δ; 175.7 (C), 
95.1 (d, JP = 13 Hz, CH), 92.8 (d, JP = 11 Hz, CH), 70.8 (CH2), 68.5 (CH), 64.0 (CH), 
57.9 (CH), 56.1 (CH), 36.3 (d, JP = 42 Hz, C), 34.3 (CH2), 31.8 (CH), 31.3 (CH2), 29.8 
(CH2), 28.9 (d, JP = 9 Hz, CH), 28.0 (CH2), 26.9 (d, J = 4 Hz, 3 x CH3), 19.8 (CH3), 19.3 
(CH3), 17.1 (CH3), 15.1 (CH3), 8.7 (d, JP = 27 Hz, CH3) ppm. 31P NMR (202 MHz, 
CDCl3) δ; 61.9 (s) ppm. HRMS (nanoESI-Orbi) m/z: [M]+ Calcd for C23H43ON2IrP 
587.2737; Found 587.2721. HRMS (nanoESI-Orbi) m/z: [M]‒ Calcd for BF4 87.0035; 
Found 87.0034. 
General procedure for the synthesis of imines. The corresponding ketone (1 eq) was 
dissolved in a dry, N2 purged round bottom flask in anhydrous Et2O (0.5 M). Then the 
corresponding amine (3 eq) was added. The mixture was cooled to 0 ºC. Then neat TiCl4 
(0.5 eq) was carefully added dropwise via syringe. The reaction was left stirring overnight 
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at room temperature. The solution was then filtered through Celite® with extra Et2O. The 
solvent was then removed under reduced pressure to obtain the crude as an oil. The crudes 
were purified by either crystallization or Kugelrohr distillation.  
Acetophenone N-phenyl imine.3a Yield: 73% (10.9 g). 1H NMR (400 MHz, CDCl3) 
δ; 8.02 – 7.91 (m, 2H), 7.55 – 7.40 (m, 3H), 7.41 – 7.30 (m, 2H), 7.13 – 7.04 (m, 1H), 
6.84 – 6.76 (m, 2H), 2.23 (s, 3H) ppm.  
4-Methoxyacetophenone N-phenyl imine.3a Yield: 63% (9.5 g). 1H NMR (400 MHz, 
CDCl3) δ; 8.04 – 7.92 (m, 2H), 7.39 – 7.31 (m, 2H), 7.10 – 7.04 (m, 1H), 6.98 – 6.93 (m, 
2H), 6.82 – 6.76 (m, 3H), 3.87 (s, 3H), 2.20 (s, 3H) ppm. 
3-Methoxyacetophenone N-phenyl imine.13 Yield: 38% (5.7 g). 1H NMR (400 MHz, 
CDCl3) δ; 7.61 – 7.54 (m, 1H), 7.53 – 7.48 (m, 1H), 7.39 – 7.31 (m, 3H), 7.11 – 7.06 (m, 
1H), 7.04 – 7.00 (m, 1H), 6.81 – 6.77 (m, 2H), 3.88 (s, 3H), 2.22 (s, 3H) ppm. 
2-Methoxyacetophenone N-phenyl imine. Yield: 33% (5.4 g). 1H NMR (400 MHz, 
CDCl3) δ; 7.61 – 7.57 (m, 1H), 7.41 – 7.32 (m, 3H), 7.04 – 7.00 (m, 1H), 6.97 – 6.93 (m, 
1H), 6.87 – 6.84 (m, 2H), 6.78 – 6.73 (m, 1H), 6.68 – 6.64 (m, 1H), 3.88 (s, 3H), 2.19 (s, 
3H) ppm. 
Acetophenone N-(4-methoxyphenyl) imine.3a Yield: 55% (5.3 g). 1H NMR (400 
MHz, CDCl3) δ; 8.03 – 7.89 (m, 2H), 7.50 – 7.39 (m, 3H), 6.93 – 6.87 (m, 2H), 6.80 – 
6.72 (m, 2H), 3.82 (s, 3H), 2.25 (s, 3H) ppm.  
1-(Naphthalen-2-yl)-N-phenylethan-1-imine.14 Yield: 62% (5.4 g). 1H NMR (400 
MHz, CDCl3) δ; 8.37 – 8.33 (m, 1H), 8.24 – 8.21 (m, 1H), 7.95 – 7.85 (m, 3H), 7.57 – 




N,1-Diphenylpropan-1-imine.3a Yield: 47% (3.7 g). 1H NMR (400 MHz, CDCl3) δ; 
7.95 – 7.90 (m, 2H), 7.48 – 7.42 (m, 3H), 7.37 – 7.31 (m, 2H), 7.07 (tt, J = 8, 1 Hz, 1H), 
6.81 – 6.77 (m, 2H), 2.66 (q, J = 8 Hz, 2H), 1.08 (t, J = 8 Hz, 3H) ppm. 
4-Chloroacetophenone N-phenyl imine.3a Yield: 51% (9.0 g). 1H NMR (400 MHz, 
CDCl3) δ; 7.94 – 7.88 (m, 2H), 7.43 – 7.38 (m, 2H), 7.38 – 7.32 (m, 2H), 7.12 – 7.06 (m, 
1H), 6.81 – 6.76 (m, 2H), 3.08 (q, J = 7 Hz, 1H), 2.21 (s, 3H), 1.40 (t, J = 7 Hz, 1H) ppm. 
Acetophenone N-(3,5-dimethylphenyl) imine.15 Yield: 57% (7.1 g). 1H NMR (400 
MHz, CDCl3) δ; 7.98 – 7.94 (m, 2H), 7.48 – 7.40 (m, 3H), 6.72 (tp, J = 1, 1 Hz, 1H), 6.44 
– 6.40 (m, 2H), 2.32 – 2.30 (m, 6H), 2.23 (s, 3H) ppm. 
Acetophenone N-(p-tolyl) imine.16 Yield: 40% (7.2 g). 1H NMR (400 MHz, CDCl3) 
δ; 8.01 – 7.92 (m, 2H), 7.48 – 7.41 (m, 3H), 7.18 – 7.14 (m, 2H), 6.73 – 6.67 (m, 2H), 
2.35 (s, 3H), 2.24 (s, 3H) ppm.   
General Procedure for the hydrogenation at high H2 pressure. The corresponding 
imine (1 eq) and the corresponding catalyst (0.01 eq) were placed along with stirring bar 
in a glass tube inside a stainless steel high pressure reactor. The reactor was entered into 
a glove box and deoxygenated anhydrous solvent was added (0.17 M). The reactor was 
closed, removed from the glove box and connected to a hydrogen manifold. While 
stirring, the reactor was purged with vacuum-hydrogen cycles and then it was charged at 
the designated pressure. The hydrogen manifold was unplugged and the mixture was left 
to stir overnight at room temperature. The reactor was depressurized and the reaction was 
concentrated under vacuum. The conversion was determined by 1H NMR. Catalyst was 
removed by filtration of the crude reaction through a short silica pad with CH2Cl2 and 




General Procedure for the hydrogenation at atmospheric H2 pressure. The 
corresponding imine (1 eq) and the corresponding catalyst (0.01 eq) were placed in a 
round bottom flask. The flask was purged with N2 and deoxygenated anhydrous solvent 
was added (0.17 M). The reaction was then set at the desired temperature. While stirring, 
a H2 filled balloon was connected. Using another needle as a gas exit the round bottom 
flask was purged with H2 until the solution went from orange to yellow (usually less than 
3-4 minutes). The gas exit was removed and the reaction was left stirring overnight. The 
next day the reaction was concentrated under vacuum. The conversion was determined 
by 1H NMR. Catalyst was removed by filtration of the crude reaction through a short 
silica pad with CH2Cl2 and concentrated under vacuum. At this point, yield and 
enantiomeric excess were determined. 
N-(1-phenylethyl)aniline.3a Yield: 97% (66 mg). 1H NMR (400 MHz, CDCl3) δ; 7.41 
– 7.25 (m, 4H), 7.28 – 7.18 (m, 1H), 7.18 – 7.03 (m, 2H), 6.68 – 6.59 (m, 1H), 6.55 – 
6.46 (m, 2H), 4.48 (q, J = 7 Hz, 1H), 4.02 (br s, 1H), 1.51 (dd, J = 7, 1 Hz, 3H) ppm. 
HPLC: CHIRALCEL OD-H. Heptane/i-PrOH 90:10, 1 mL/min, λ = 220 nm. tR(+)= 15.4 
min, tR(–)= 17.0 min. (ee = 96%).  
N-(1-(4-methoxyphenyl)ethyl)aniline.3a Yield: 96% (76 mg). 1H NMR (400 MHz, 
CDCl3) δ; 7.30 – 7.26 (m, 2H), 7.11 – 7.06 (m, 2H), 6.87 – 6.84 (m, 2H), 6.53 – 6.47 (m, 
2H), 4.44 (q, J = 6.7 Hz, 1H), 3.78 (s, 3H), 1.49 (d, J = 6.7 Hz, 3H) ppm. HPLC: Chiralpak 
IA. Heptane/i-PrOH 96:4, 0.5 mL/min, λ = 210 nm. tR(+)= 16.1 min, tR(–)= 17.6 min. (ee 
= 95%).  
N-(1-(3-methoxyphenyl)ethyl)aniline.13 Yield: 98% (77 mg). 1H NMR (400 MHz, 
CDCl3) δ; 7.26 – 7.21 (m, 1H), 7.11 – 7.05 (m, 2H), 6.98 – 6.94 (m, 1H), 6.94 – 6.91 (m, 
1H), 6.76 (ddd, J = 8, 3, 1 Hz, 1H), 6.64 (tt, J = 7, 1 Hz, 1H), 6.54 – 6.48 (m, 2H), 4.45 
(q, J = 7 Hz, 1H), 4.01 (s, 1H), 3.78 (s, 3H), 1.51 (d, J = 7 Hz, 3H) ppm. HPLC: 
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CHIRALCEL OJ. Heptane/EtOH 50:50-0.2% DEA, 0.5 mL/min, λ = 210 nm. tR(+)= 18.1 
min, tR(–)= 20.8 min. (ee = 92%). 
N-(1-(2-methoxyphenyl)ethyl)aniline.17 Yield: 96% (75 mg).  1H NMR (400 MHz, 
CDCl3) δ; 7.27 – 7.20 (m, 1H), 7.15 – 7.08 (m, 1H), 7.03 – 6.96 (m, 2H), 6.83 – 6.77 (m, 
2H), 6.54 (tt, J = 7, 1 Hz, 1H), 6.46 – 6.37 (m, 2H), 4.77 (q, J = 7 Hz, 1H), 3.82 (s, 3H), 
1.40 (d, J = 7 Hz, 3H) ppm. HPLC: CHIRALCEL OJ. Heptane/EtOH 70:30-0.2% DEA, 
0.5 mL/min, λ = 210nm. tR(+)= 14.5 min, tR(–)= 19.1 min. (ee = 28%).  
4-methoxy-N-(1-phenylethyl)aniline.3a Yield: 98% (77 mg). 1H NMR (400 MHz, 
CDCl3) δ; 7.39 – 7.28 (m, 4H), 7.24 – 7.19 (m, 1H), 6.74 – 6.61 (m, 2H), 6.47 (d, J = 9 
Hz, 2H), 4.41 (q, J = 7 Hz, 1H), 3.69 (s, 3H), 1.50 (d, J = 7 Hz, 3H) ppm. HPLC: Chiralpak 
IC Heptane/i-PrOH 96:4, 0.5 mL/min, λ = 210 nm. tR(+)= 17.3 min, tR(–)= 18.4 min. (ee 
= 93%). 
N-(1-(naphthalen-2-yl)ethyl)aniline.18 Yield: 96% (82 mg). 1H NMR (400 MHz, 
CDCl3) δ; 7.84 – 7.77 (m, 4H), 7.50 (dd, J = 8, 2 Hz, 1H), 7.48 – 7.39 (m, 2H), 7.13 – 
7.03 (m, 2H), 6.66 – 6.59 (m, 1H), 6.59 – 6.53 (m, 2H), 4.64 (q, J = 7 Hz, 1H), 4.18 – 
4.04 (m, 1H), 1.59 (d, J = 7 Hz, 3H) ppm. HPLC: CHIRALCEL OJ. Heptane/EtOH 50:50, 
0.8 mL/min, λ = 210 nm. tR(+)= 14.4 min, tR(–)= 17.2 min. (ee = 94%). 
N-(1-phenylpropyl)aniline.3a Yield: 99% (72 mg).  1H NMR (400 MHz, CDCl3) δ; 
7.39 – 7.27 (m, 4H), 7.27 – 7.18 (m, 1H), 7.11 – 7.04 (m, 2H), 6.62 (tt, J = 7, 1 Hz, 1H), 
6.56 – 6.43 (m, 2H), 4.22 (t, J = 7 Hz, 1H), 4.04 (br s, 1H), 1.90 – 1.72 (m, 2H), 0.95 (t, 
J = 7 Hz, 3H) ppm. HPLC: CHIRALCEL OD-H. Heptane/i-PrOH 95:5, 0.5 mL/min, λ = 
210 nm. tR(+)= 11.9 min, tR(–)= 14.8 min. (ee = 74%). 
N-(1-(4-chlorophenyl)ethyl)aniline.3a Yield: 98% (78 mg).  1H NMR (400 MHz, 
CDCl3) δ; 7.25 – 7.18 (m, 4H), 7.05 – 6.97 (m, 2H), 6.62 – 6.54 (m, 1H), 6.43 – 6.35 (m, 
2H), 4.38 (q, J = 7 Hz, 1H), 1.42 (d, J = 7 Hz, 3H) ppm. HPLC: CHIRALCEL OD-H. 
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Heptane/i-PrOH 95:5, 1 mL/min, λ = 210 nm. tR(+)= 10.4 min, tR(–)= 14.8 min. (ee = 
94%). 
3,5-dimethyl-N-(1-phenylethyl)aniline.19 Yield: 99% (77 mg). 1H NMR (400 MHz, 
CDCl3) δ; 7.38 – 7.28 (m, 3H), 7.24 – 7.19 (m, 1H), 6.32 – 6.27 (m, 1H), 6.18 – 6.10 (m, 
2H), 4.47 (q, J = 7 Hz, 1H), 3.90 (br s, 1H), 2.16 (s, 6H), 1.49 (d, J = 7 Hz, 3H) ppm. 
HPLC: CHIRALCEL OD-H. Heptane/i-PrOH 95:5, 0.5 mL/min, λ = 254 nm. tR(+)= 10.7 
min, tR(–)= 12.4 min. (ee = 90%). 
4-methyl-N-(1-phenylethyl)aniline.20 Yield: 96% (70 mg). 1H NMR (400 MHz, 
CDCl3) δ; 7.38 – 7.28 (m, 4H), 7.24 – 7.19 (m, 1H), 6.94 – 6.84 (m, 2H), 6.47 – 6.39 (m, 
2H), 4.45 (q, J = 7 Hz, 1H), 2.18 (s, 3H), 1.50 (d, J = 7 Hz, 3H) ppm. HPLC: CHIRALCEL 
OJ. Heptane/i-PrOH 50:50, 1 mL/min, λ = 210 nm. tR(+)= 12.2 min, tR(–)= 15.4 min. (ee 
= 95%). 
General Procedure for synthesis of imine iridacycles. In a round bottom flask 100 
mg of complex ent-1b or ent-3b (0.069 mmol, 1 eq) and 27 mg of acetophenone N-phenyl 
imine (0.138 mmol, 2 eq) were placed. The flask was then purged with N2 and THF (2 
mL) was added. The solution was purged with a balloon of H2 until the orange color 
changed to yellow. The reaction mixture was stirred at room temperature during 4 hours. 
The solvent was removed with a N2 flow and LiCl (100 mg), SiO2 (100 mg) and EtOAc 
(2 mL) were added. The reaction was left to stir overnight. The solvent was again removed 
with a N2 flow. The crude was suspended in pentane/TBME (1:1) and eluted through 
SiO2. Only the yellow colored band was collected affording the desired products. The 
complexes were crystalized with hexanes/DCM to obtain single crystals for X-ray 
analysis. 
[IrHCl(P*,N)(imine)] (9). Yellow solid. Yield: 60% (29 mg). 1H NMR (400 MHz, 
CD2Cl2) δ; 7.80 – 7.68 (m, 2H), 7.57 – 7.50 (m, 1H), 7.40 – 7.30 (m, 2H), 7.17 (tt, J = 7, 
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1 Hz, 1H), 6.96 – 6.91 (m, 3H), 5.02 – 4.96 (m, 1H), 4.30 (dd, J = 9, 5 Hz, 1H), 3.98 (dd, 
J = 10, 9 Hz, 1H), 3.01 – 2.93 (m, 1H), 2.74 – 2.65 (m, 1H), 2.41 (s, 3H), 1.86 (dd, J = 9, 
1 Hz, 3H), 1.84 – 1.78 (m, 1H), 1.12 (br d, J = 10 Hz, 1H), 0.86 (d, J = 7 Hz, 3H), 0.81 
(d, J = 7 Hz, 3H), 0.78 (d, J = 7 Hz, 3H), 0.64 (d, J = 7 Hz, 3H), 0.57 (d, JP = 14 Hz, 9H), 
-19.76 (d, JP(cis) = 26 Hz, 1H) ppm. 13C NMR (101 MHz, CD2Cl2) δ; 180.0 (C), 168.5 (C), 
155.6 – 154.2 (m, C), 149.5 (C), 148.4 (C), 143.2 (d, J = 1 Hz, CH), 130.6 (CH), 129.2 
(CH), 128.4 – 127.7 (m, 2 x CH), 125.5 (CH), 123.6 (CH), 121.9 (CH), 119.8 (CH), 68.8 
(CH2), 67.5 (CH), 57.5 (d, J = 2 Hz, CH), 37.4 (d, JP = 37 Hz, C), 28.1 (d, J = 8 Hz, CH), 
27.8 (CH), 25.8 (d, J = 4 Hz, 3 x CH3), 22.3 – 21.3 (m, CH3), 20.1 (CH3), 18.2 (CH3), 
17.6 (CH3), 16.8 (CH3), 13.4 (CH3) ppm. 31P NMR (202 MHz, CDCl3) δ; 36.3 (d, JH = 
20 Hz) ppm. HRMS (nanoESI-Orbi) m/z: [M – Cl]+ Calcd for C29H44IrN3OP 674.2846; 
Found 674.2834. 
[IrHCl(P*,N)(imine)] (10). Yellow solid. Yield: 56% (27 mg). 1H NMR (400 MHz, 
CD2Cl2) δ; 7.85 – 7.56 (m, 2H), 7.51 – 7.48 (m, 1H), 7.41 – 7.26 (m, 2H), 7.15 (tt, J = 8, 
1 Hz, 1H), 7.01 – 6.74 (m, 3H), 4.93 (dtd, J = 9, 3, 1 Hz, 1H), 4.20 (dd, J = 9, 3 Hz, 1H), 
3.73 – 3.68 (m, 1H), 3.65 (dd, J = 9, 9 Hz, 1H), 2.89 (hd, J = 7, 3 Hz, 1H), 2.35 (s, 3H), 
2.07 – 1.95 (m, 1H), 1.55 – 1.49 (m, 1H), 1.07 (d, JP = 15 Hz, 9H), 0.90 (d, JP = 9 Hz, 
3H), 0.86 (d, J = 7 Hz, 3H), 0.77 (d, J = 7 Hz, 3H), 0.63 (d, J = 7 Hz, 3H), 0.43 (d, J = 7 
Hz, 3H), -19.62 (d, JP(CIS) = 23 Hz, 1H) ppm. 13C NMR (101 MHz, CD2Cl2) δ; 180.3 (C), 
162.1 (C), 154.3 (C), 149.6 (C), 148.3 (C), 143.4 (2 x CH), 130.4 (CH), 128.7 (2 x CH), 
128.6 (CH), 125.3 (CH), 119.6 (2 x CH), 70.3 (CH), 67.5 (CH2), 57.8 (CH), 36.2 (d, JP = 
43 Hz, C), 30.6 (d, J = 6 Hz, CH), 28.6 (CH), 26.4 (3 x CH3), 19.4 (CH3), 18.3 (CH3), 
17.4 (CH3), 16.2 (CH3), 13.6 (CH3), 9.1 (d, JP = 42 Hz, CH3) ppm. 31P NMR (202 MHz, 
CDCl3) δ; 43.93 (d, JH = 19 Hz) ppm. HRMS (nanoESI-Orbi) m/z: [M – Cl]+ Calcd for 
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